Thiopropionamides, and the pharmaceutical compositions
    5.
    发明授权
    Thiopropionamides, and the pharmaceutical compositions 失效
    硫丙酰胺和药物组合物

    公开(公告)号:US4283407A

    公开(公告)日:1981-08-11

    申请号:US945253

    申请日:1978-09-25

    CPC分类号: C07D277/06 C07D279/12

    摘要: This invention relates to omega-mercaptopropionylamides, the nitrogen atom of which is included as a ring atom of a cyclic amino acid.The application also discloses a process for producing said compounds which comprises reacting an omega-mercaptopropionic acid, or a functional derivative thereof, with a cyclic amino acid.This invention further relates to pharmaceutical compositions incorporating such an omega-mercaptopropionylamide as active ingredient together with a pharmaceutically-acceptable carrier or vehicle, and a method of employing said compounds.They find a use in human therapy, namely, as antihypertensive agents.

    摘要翻译: 本发明涉及ω-巯基丙酰胺,其氮原子作为环状氨基酸的环原子包括在内。 本申请还公开了一种制备所述化合物的方法,其包括使ω-巯基丙酸或其官能衍生物与环状氨基酸反应。 本发明进一步涉及将这样的ω-巯基丙酰胺作为活性成分与药学上可接受的载体或赋形剂以及使用所述化合物的方法结合的药物组合物。 它们用于人类治疗,即作为抗高血压药物。

    N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy
    6.
    发明授权
    N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy 失效
    N- [苯基(哌啶-2-基)甲基]苯甲酰胺衍生物,其制备及其在治疗中的用途

    公开(公告)号:US07951821B2

    公开(公告)日:2011-05-31

    申请号:US11680782

    申请日:2007-03-01

    IPC分类号: A61K31/445

    CPC分类号: C07D211/26

    摘要: This invention discloses and claims a compound of general formula (I) in which R1 represents either a hydrogen atom, or an optionally substituted alkyl group, or a cycloalkylalkyl group, or an optionally substituted phenylalkyl group, or an alkenyl group, X represents a hydrogen atom or one or more substituents chosen from halogen atoms and trifluoromethyl, alkyl and alkoxy groups, R2 represents one or more substituents chosen from halogen atoms, optionally substituted alkoxy and optionally substituted amino. The compounds of this invention exhibit therapeutic utility.

    摘要翻译: 本发明公开了一种通式(I)的化合物,其中R 1表示氢原子或任选取代的烷基,或环烷基烷基,或任选取代的苯基烷基或烯基,X表示氢 原子或一个或多个选自卤素原子和三氟甲基,烷基和烷氧基的取代基,R 2表示一个或多个选自卤素原子,任选取代的烷氧基和任选取代的氨基的取代基。 本发明的化合物表现出治疗效用。